Description
A cell-permeable PKC inhibitor (IC50s = 2.45 and 25.7 µM for PKC and PKA, respectively); reduces focus formation in gangciclovir-sensitive and -resistant human cytomegalovirus (HCMV) strains with IC50s of 0.32 and 0.17 µM for HCMV A6245 and HCMV-6, respectively; inhibits the non-kinase enzymes β-lactamase, chymotrypsin, and malate dehydrogenase with IC50s of 8, 10, and 8 µM
Formal name: 6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one
Synonyms: SD 1825|Staurosporine aglycone
Molecular weight: 311.3
CAS: 85753-43-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Kinase Inhibitors|PKC||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|PKC Signaling||Research Area|Cell Biology|Proteolysis|Cytosolic & Secreted Proteases||Research Area|Infectious Disease|Viral Diseases